- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FE: FE (III) ION(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 0LV: (2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)methanol(Non-covalent)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feder, D. et al., Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics. Chem.Biol.Drug Des. (2012)
- Release Date
- 2012-09-19
- Peptides
- Purple acid phosphatase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
C